New comparative performance data published for authorized COVID-19 molecular diagnostic tests

New comparative performance data published for authorized COVID-19 molecular diagnostic tests

Reviewed by Emily Henderson, B.Sc.Sep 16 2020
Today, the U.S. Food and Drug Administration published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The tables show the Limit of Detection (LoD) of more than 55 authorized molecular diagnostic COVID-19 tests against a standardized sample panel provided by the FDA.

The FDA provided these standardized samples, known as a reference panel, to test developers who are required to assess their test’s performance against this panel (or other FDA-recommended reference materials) as a condition of… #comparative #performance #data #published #authorized #COVID19 #molecular #diagnostic #tests